Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...
Remission doesn’t necessarily mean that the cancer is completely removed from the body. Though it does mean that doctors ...